Biotech Tools Are Slowing Down Drug Development Process, Study Finds | GenomeWeb

NEW YORK, Nov. 14—Hurry up and wait: the biotech revolution, touted as the transformation that would speed sluggish drug development times and boost efficiency in the pharmaceutical industry, seems so far to have slowed the process down. The finding comes from a new study released Tuesday by the Tufts Center for the Study of Drug Development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.